NCT03234725

Brief Summary

The aim of the present study is to develop and evaluate a computer-based methods for automated and improved detection and classification of different colorectal lesions, especially polyps. For this purpose first, pit pattern and vascularization features of up to 1000 polyps with a size of 10 mm or smaller will be detected and stored in our web based picture database made by a zoom BLI colonoscopy. These polyps are going to be imaged and subsequently removed for histological analysis. The polyp images are analyzed by a newly developed deep learning computer algorithm. The results of the deep learning automatic classification (sensitivity, specificity, negative predictive value, positive predictive value and accuracy) are compared to those of human observers, who were blinded to the histological gold standard. In a second approach we are planning to use LCI of the colon, rather than the usual white light. Here, we will determine, whether this technique could improve the detection of flat neoplastic lesions, laterally spreading tumors, small pedunculated adenomas and serrated polyps. The polyps are called serrated because of their appearance under the microscope after they have been removed. They tend to be located up high in the colon, far away from the rectum. They have been definitely shown to be a type of precancerous polyp and it is possible that using LCI will make it easier to see them, as they can be quite difficult to see with standard white light.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2016

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

July 27, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 31, 2017

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2018

Completed
Last Updated

July 10, 2019

Status Verified

July 1, 2019

Enrollment Period

2 years

First QC Date

July 27, 2017

Last Update Submit

July 9, 2019

Conditions

Keywords

Blue light imagingLinked color imagingOptical histologyAdenoma detection rateVariable stiffnessDeep learning

Outcome Measures

Primary Outcomes (7)

  • diagnostic value of the computer algorithm

    diagnostic value of the computer algorithm (sensitivity, specificity, negative predictive value, positive predictive value, accuracy) \[ Time Frame: 10 months \] \[ Designated as safety issue: No \]

    2 years

  • Number of detected serrated polyps

    Number of Detected Proximal Serrated lesions, flat polyps and colorectal adenomas in proximal colon

    2 years

  • Number of detected polyps

    Quantity of total number of colorectal adenomas found in the colon during colonoscopy was recorded and compared.

    2 years

  • the accuracy of the NICE (NBI International Colorectal Endoscopic) criteria using FICE versus BLI Eluxeo technology

    the accuracy of the NICE criteria using FICE versus BLI Eluxeo technology without optical zoom for differentiating between the non-neoplastic and neoplastic histotypes in diagnoses with high-confidence on a video-library of 120 polyps reviewed by 5 experts. 5 experts will review pictures from a web-library of subcentimetric polyps removed and histologically verified and will assess each of the three NICE criteria (colour/vascularization/surface), and classify the lesion as neoplastic or non-neoplastic with low or high confidence.

    2 years

  • Inter-observer agreement among the 5 experts

    Inter-observer agreement among the 5 experts \[ Time Frame: up to 6 months \] \[ Designated as safety issue: No \] The inter-observer agreement, among the 5 experts, on the final diagnosis (neoplastic or non-neoplastic) and on each individual NICE criterion for each polyp will be determined by using K statistics.

    2 years

  • Cecal intubation rate

    The proportion of colonoscopy procedures resulting in successful intubation of the cecum.

    2 years

  • Propofol need for deep sedation

    The main efficacy parameter is the amount of Propofol used for deep sedation during colonoscopy, expressed as the mean for each group.

    2 years

Secondary Outcomes (6)

  • diagnostic interobserver variability based on the computer algorithm

    2 years

  • the accuracy of the NICE criteria using FICE versus BLI Eluxeo technology with 50x optical zoom for differentiating between the non-neoplastic and neoplastic histotypes

    2 years

  • Comparison of accuracy of BLI and LCI pictures

    2 years

  • Improvement of adenoma detection rate by using LCI imaging comparing with that under white endoscopy

    2 years

  • Time-to-cecum

    2 years

  • +1 more secondary outcomes

Study Arms (2)

LCI out group

The whitdrawal of the colonoscop happen in LCI mode.

WL (white light) out group

The whitdrawal of the colonoscop happen in WL mode.

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All adult patients who did not meet the exclusion criteria were included in the study

You may qualify if:

  • The patient must sign, understand and provide written consent for the procedure.
  • Undergoing colonoscopy at our endoscopy unit for any indication in Propofol deep sedation
  • Intact colon and rectum
  • ASA (American Society of Anesthesiology) risk class 1, 2 or 3

You may not qualify if:

  • Patients with inflammatory bowel disease;
  • Patients with poor bowel preparation; (Boston score \<4)
  • Female patients with pregnancy;
  • Patients with mechanical bowel obstruction;
  • Patients with diverticulitis or toxic megacolon;
  • Patients with a history of radiation therapy to abdomen or pelvis;
  • Patients with a history of severe cardiovascular, pulmonary, liver or renal disease and high ASA (\>3) risk of propofol sedation;
  • Personal history of coagulation disorders or use of anticoagulants;
  • Patients who are currently enrolled in another clinical investigation in which the intervention might compromise the safety of the patient's participation in this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bács Kiskun County and Teaching Hospital

Kecskemét, Nyiri Street 38, 6000, Hungary

Location

Study Officials

  • Laszlo Madacsy, MD,pHd

    Bács Kiskun Coeunty Teaching Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

July 27, 2017

First Posted

July 31, 2017

Study Start

October 1, 2016

Primary Completion

September 30, 2018

Study Completion

September 30, 2018

Last Updated

July 10, 2019

Record last verified: 2019-07

Data Sharing

IPD Sharing
Will not share

Locations